Role of podoplanin in the high interleukin-17A secretion resulting from interactions between activated lymphocytes and psoriatic skin-derived mesenchymal cells

Clinical and Experimental Immunology

Volumn 186, Issue 1, 2016, Pages 64-74

  Noack, M ^a   Ndongo Thiam, N D ^a   Miossec, P ^a  

^a University of Lyon   (France)

Author keywords

cell interactions; IL 17; immune cells; podoplanin; psoriasis; skin fibroblasts

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PODOPLANIN;

ARTICLE; CELL ACTIVATION; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IN VITRO STUDY; LYMPHOCYTE; MESENCHYME CELL; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PSORIASIS; SKIN FIBROBLAST; TH17 CELL;

EID: 84991251631     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12830     Document Type: Article

References (39)

1. Griffiths CE, Barker JN. Pathogenesis and clinical features of psoriasis. Lancet 2007; 370:263–71.
2. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med 2009; 361:496–509.
3. Di Cesare A, Di Meglio P, Nestle FO. The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 2009; 129:1339–50.
4. Martin DA, Towne JE, Kricorian G et al. The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings. J Invest Dermatol 2013; 133:17–26.
5. Maddur MS, Miossec P, Kaveri SV et al. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol 2012; 181:8–18.
6. Miossec P, Kolls JK. Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov 2012; 11:763–76.
7. Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009; 361:888–98.
8. Benham H, Norris P, Goodall J et al. Th17 and Th22 cells in psoriatic arthritis and psoriasis. Arthritis Res Ther 2013; 15:R136.
9. Kagami S, Rizzo HL, Lee JJ et al. Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J Invest Dermatol 2010; 130:1373–83.
10. Kryczek I, Bruce AT, Gudjonsson JE et al. Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis. J Immunol 2008; 181:4733–41.
11. Lowes MA, Kikuchi T, Fuentes-Duculan J et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 2008; 128:1207–11.
12. Langley RG, Elewski BE, Lebwohl M et al. Secukinumab in plaque psoriasis–results of two phase 3 trials. N Engl J Med 2014; 371:326–38.
13. Mease PJ, Genovese MC, Greenwald MW et al. Brodalumab, an anti-IL17RA monoclonal antibody, in psoriatic arthritis. N Engl J Med 2014; 370:2295–306.
14. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003; 423:356–61.
15. Conrad C, Boyman O, Tonel G et al. Alpha1beta1 integrin is crucial for accumulation of epidermal T cells and the development of psoriasis. Nat Med 2007; 13:836–42.
16. Eljaafari A, Tartelin ML, Aissaoui H et al. Bone marrow-derived and synovium-derived mesenchymal cells promote Th17 cell expansion and activation through caspase 1 activation: contribution to the chronicity of rheumatoid arthritis. Arthritis Rheum 2012; 64:2147–57.
17. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A et al. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007; 8:942–9.
18. Wilson NJ, Boniface K, Chan JR et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007; 8:950–7.
19. Yang L, Anderson DE, Baecher-Allan C et al. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 2008; 454:350–2.
20. Kouris A, Pistiki A, Katoulis A et al. Proinflammatory cytokine responses in patients with psoriasis. Eur Cytokine Netw 2014; 25:63–8.
21. Astarita JL, Acton SE, Turley SJ. Podoplanin: emerging functions in development, the immune system, and cancer. Front Immunol 2012; 3:283
22. Martin-Villar E, Megias D, Castel S et al. Podoplanin binds ERM proteins to activate RhoA and promote epithelial–mesenchymal transition. J Cell Sci 2006; 119:4541–53.
23. Honma M, Fujii M, Iinuma S et al. Podoplanin expression is inversely correlated with granular layer/filaggrin formation in psoriatic epidermis. J Dermatol 2013; 40:296–7.
24. Honma M, Minami-Hori M, Takahashi H et al. Podoplanin expression in wound and hyperproliferative psoriatic epidermis: regulation by TGF-beta and STAT-3 activating cytokines, IFN-gamma, IL-6, and IL-22. J Dermatol Sci 2012; 65:134–40.
25. Rey D, Manuel J. Izquierdo et al. Podoplanin-mediated interaction of rheumatoid arthritis synovial fibroblasts with platelets modulates IL-8 expression. Arthritis Rheum 2012; 64:1183.
26. Bennett WE, Cohn ZA. The isolation and selected properties of blood monocytes. J Exp Med 1966; 123:145–60.
27. Johnson WD Jr, Mei B, Cohn ZA. The separation, long-term cultivation, and maturation of the human monocyte. J Exp Med 1977; 146:1613–26.
28. Harrington LE, Mangan PR, Weaver CT. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol 2006; 18:349–56.
29. Cho ML, Yoon CH, Hwang SY et al. Effector function of type II collagen-stimulated T cells from rheumatoid arthritis patients: cross-talk between T cells and synovial fibroblasts. Arthritis Rheum 2004; 50:776–84.
30. Miranda-Carus ME, Balsa A, Benito-Miguel M et al. IL-15 and the initiation of cell contact-dependent synovial fibroblast-T lymphocyte cross-talk in rheumatoid arthritis: effect of methotrexate. J Immunol 2004; 173:1463–76.
31. Baliwag J, Barnes DH, Johnston A. Cytokines in psoriasis. Cytokine 2015; 73:342–50.
32. Ha HL, Wang H, Pisitkun P et al. IL-17 drives psoriatic inflammation via distinct, target cell-specific mechanisms. Proc Natl Acad Sci USA 2014; 111:E3422–31.
33. Hur J, Jang JH, Oh IY et al. Human podoplanin-positive monocytes and platelets enhance lymphangiogenesis through the activation of the podoplanin/CLEC-2 axis. Mol Ther 2014; 22:1518–29.
34. Acton SE, Astarita JL, Malhotra D et al. Podoplanin-rich stromal networks induce dendritic cell motility via activation of the C-type lectin receptor CLEC-2. Immunity 2012; 37:276–89.
35. Kuwabara T, Ishikawa F, Yasuda T et al. CCR7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells. J Immunol 2009; 183:2513–21.
36. Miyamoto Y, Uga H, Tanaka S et al. Podoplanin is an inflammatory protein upregulated in Th17 cells in SKG arthritic joints. Mol Immunol 2013; 54:199–207.
37. Peters A, Pitcher LA, Sullivan JM et al. Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. Immunity 2011; 35:986–96.
38. Ekwall AK, Eisler T, Anderberg C et al. The tumour-associated glycoprotein podoplanin is expressed in fibroblast-like synoviocytes of the hyperplastic synovial lining layer in rheumatoid arthritis. Arthritis Res Ther 2011; 13:R40.
39. Hoshino A, Ishii G, Ito T et al. Podoplanin-positive fibroblasts enhance lung adenocarcinoma tumor formation: podoplanin in fibroblast functions for tumor progression. Cancer Res 2011; 71:4769–79.